Newsroom | 25229 results
Sorted by: Latest
-
InterSystems nomina l'ex leader del NHS e del Mass General, Tim Ferris, come vicepresidente della divisione Healthcare Practice
LAS VEGAS--(BUSINESS WIRE)--InterSystems, leader globale nelle tecnologie per la gestione dei dati sanitari, ha annunciato oggi la nomina di Tim Ferris, M.D., a vicepresidente della divisione Healthcare. L’annuncio è stato dato in occasione della HIMSS Global Health Conference & Exhibition 2026. Nel suo nuovo ruolo, Ferris contribuirà a guidare la direzione clinica e strategica delle soluzioni sanitarie di InterSystems a livello globale, mettendo a disposizione una visione ampia e trasversa...
-
A InterSystems nomeia o Dr. Tim Ferris, ex-líder do NHS e do Mass General, como vice-presidente da área de saúde
LAS VEGAS--(BUSINESS WIRE)--A InterSystems, um fornecedor de tecnologia de dados criativos que alimenta mais de mil milhões de registos de saúde em todo o mundo, anunciou hoje a nomeação de Tim Ferris, M.D., como Vice-Presidente da Prática de Cuidados de Saúde. O anúncio surge no momento em que os líderes do sector da saúde se reúnem para a Conferência e Exposição Mundial de Saúde HIMSS de 2026. Nesta função, o Dr. Ferris irá tirar partido da sua visão abrangente do setor para ajudar a impulsio...
-
InterSystems nomme le Dr Tim Ferris, ancien directeur du NHS et du Mass General, au poste de vice-président du département Santé
LAS VEGAS--(BUSINESS WIRE)--InterSystems, fournisseur de technologies de données créatives alimentant plus d'un milliard de dossiers médicaux dans le monde, a annoncé aujourd'hui la nomination de Tim Ferris, M.D., au poste de vice-président du département Santé. Cette annonce a été faite alors que les responsables du secteur de la santé se réunissent à l'occasion de la conférence et du salon HIMSS Global Health 2026. Dans le cadre de ses fonctions, le Dr Ferris s'appuiera sur sa vision globale...
-
RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry
IRVINE, Calif.--(BUSINESS WIRE)--RIS Rx unveils new brand highlighting real-time GTN Revenue Protection, helping pharma manufacturers stop revenue leakage and protect patients....
-
Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced new real-world evidence (RWE) demonstrating improved time in range (TIR) through the use of Welldoc’s Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. For the millions of people who use bolus insulin, daily management is a burden. People with insulin-dependent diabetes make numerous, complex health-related decisions every day. When calculating a mealtime dose, in...
-
OXOS Medical Unlocks Pediatric Imaging for MC2 Portable X-ray
ATLANTA--(BUSINESS WIRE)--OXOS Medical® today announced that its MC2 portable X-ray system is now cleared for pediatric imaging....
-
GE HealthCare appoints medtech leader Kevin Lobo to Board of Directors
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the appointment of Kevin A. Lobo, Chair and Chief Executive Officer of Stryker Corporation (NYSE: SYK), to its Board of Directors effective March 13. Mr. Lobo brings more than 25 years of medical technology, operational, and financial leadership experience. His clinical expertise and track record of driving innovation and scaling global businesses make him well qualified to contribute to GE HealthCare’s strategic priorities....
-
Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global nonprofit focused on blood cancer patient support, research, and advocacy, today announced a strategic collaboration to develop a comprehensive, patient-centered, real-world registry for pediatric acute myeloid leukemia (pAML), a rare and aggressive blood cancer. Part of...
-
Stratasys TrueDent Becomes the First High-esthetic, Monolithic 3D-printed Denture Solution to Achieve Certification in Europe, a $2 Billion+ Market
MINNETONKA, Minn. & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (NASDAQ: SSYS) today announced that its TrueDent® resins have received CE marking as a Class IIa medical device, making them Europe’s first high-esthetic, monolithic 3D-printed denture solution to achieve certification in the more than $2 billion market. This milestone enables broader regulated clinical use and expands patient access to polychromatic, monolithic 3D-printed dentures, removable partial dentures, and crowns and b...
-
Trice Medical Launches Tenex® 2nd Generation Ultrasonic System, Expanding Minimally Invasive Treatment for Chronic Tendon Pain
MALVERN, Pa.--(BUSINESS WIRE)--Trice Medical today announced nationwide commercial availability of the FDA-cleared Tenex® 2nd Generation System, building on the proven Tenex Health TX® platform that has been used in more than 240,000 procedures. The Tenex 2nd Generation System is an advanced platform designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions, including calcific deposits, bone spurs, and diabetic f...
